Emerging evidence has indicated that ARHGAP10 suppressed CRC proliferation and metastasis by inhibiting the activity of Rho/Akt signaling pathway [33], consistent with our results that ARHGAP10 down-regulated PI3K/Akt activity in NSCLC cells. This evidence concerns the gene ARHGAP10 and colorectal carcinoma.